Lipid‐lowering effects of WAY‐121,898, an inhibitor of pancreatic cholesteryl ester hydrolase
- 1 May 1998
- Vol. 33 (5), 489-98
- https://doi.org/10.1007/s11745-998-0232-8
Abstract
WAY-121,898 is an inhibitor of pancreatic cholesteryl ester hydrolase (pCEH). After confirming its in vitro potency and relative lack of a major effect on acyl-CoA:cholesterol acyltransferase (ACAT), it was found that this compound lowers plasma cholesterol in cholesterol-fed, but not chow-fed, rats. Measures of liver cholesteryl ester content and the direct determination of cholesterol absorption (lymph-fistula model) show that inhibition of cholesterol absorption is at least one mechanism for the observed cholesterol lowering. However, WAY-121,898 was also active when administered parenterally to cholesterol-fed rats, and in cholesterol-fed hamsters cholesterol-lowering occurred with oral dosing despite no change in cholesterol absorption, suggesting other modes of action possibly relating to inhibition of liver CEH. Combination treatment in cholesterol-fed rats with the ACAT inhibitor CI-976 resulted in a greater-than-additive reduction in plasma cholesterol, imlying that both pCEH and ACAT may play a role in cholesterol absorption in this species. In rabbits, WAY-121,898 prevented the rise in plasma cholesterol due to the feeding of cholesteryl ester but not in rabbits fed (free) cholesterol. In guinea pigs, the compound induced an increase in adrenal cholesteryl ester mass. Taken together, the overall profile in these animal models suggests that WAY-121,898 inhibits more than just the intestinal (lumenal) pCEH, and that the role of this enzyme in cholesterol metabolism may be different within and across species, the former depending upon the dietary cholesterol load.Keywords
This publication has 45 references indexed in Scilit:
- Molecular biology of enzymes involved with cholesterol ester hydrolysis in mammalian tissuesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Biochemical alterations in guinea pig adrenal cortex following administration of pd 132301-2, an inhibitor of acyl-CoA: Cholesterol acyltransferaseLife Sciences, 1995
- Characterization of a bile salt-dependent cholesteryl ester hydrolase activity secreted from HepG2 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Molecular cloning and expression of cDNA for rat pancreatic cholesterol esteraseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Studies on hypolipidemic agents. III. Synthesis and esterase-inhibitory activity of .OMEGA.-cycloalkyl-2-oxoalkyl arenesulfonates.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Studies on hypolipidemic agents. V. Synthesis and esterase-inhibitory activity of 2-(1,4- and 4,4-dialkylcyclohexyl)-2-oxoethyl arenesulfonates.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Studies on hypolipidemic agents. IV. Syntheses and biological activities of trans- and cis-2-(4-alkylcyclohexyl)-2-oxoethyl arenesulfonates.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Studies on hypolipidemic agents. II Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Studies of hypolipidemic agents. I. Syntheses and hypolipidemic activities of 1-substituted 2-alkanone derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- The role of cholesteryl ester hydrolysis and synthesis in cholesterol transport across rat intestinal mucosal membrane a new conceptBiochemical and Biophysical Research Communications, 1982